SESH FRAGRANCE ACADEMY | ADVANCED SAFETY & COMPLIANCE
Do 'natural' and 'IFRA conforming' mean allergy is impossible?
The exclamation mark is a GHS hazard pictogram example. Its interpretation and a material’s actual classification come from its safety data sheet; this is a teaching example.
Open full-size image ↗Distinguish sensitization, irritation, exposure, allergens, oxidation and disclosure thresholds using verifiable finished-product calculations.
1. Sensitization and irritation are not interchangeable
Irritation is a local adverse effect often linked to exposure conditions, whereas allergic contact dermatitis involves an immune response in a sensitized person. Redness alone does not identify one culprit, and individual susceptibility varies. Medical diagnosis may require professionally supervised patch testing, not experimental application of neat fragrance ingredients at home. Developers must evaluate foreseeable exposure and applicable restrictions.
2. Hazard and actual risk must be separated
A sensitization hazard describes a substance's potential to elicit sensitization, while risk assessment considers concentration, route, frequency, exposed body area and user population. IFRA conformity is important but does not guarantee absence of adverse reactions or replace finished-product safety work. Tolerance observed in one person cannot support an 'allergy-proof for everyone' claim.
Eyelid and perioral reactions: stop guessing triggers — a published visual reference for the topic, not SESH product-test data.
Open full-size image ↗3. Natural extracts are not automatically gentler
Botanical fragrance extracts can naturally contain constituents such as limonene and linalool. Oxidation under some conditions can form hydroperoxides with sensitizing relevance. '100% essential oil' does not imply safe direct skin use or freedom from ingredient-disclosure obligations. Relevant exposure calculations must consider batch data and constituent contributions across all sources.
4. EU disclosure thresholds are not safety limits
Under Regulation (EU) 2023/1545, specified fragrance allergens require individual ingredient-list disclosure above 0.001% in leave-on cosmetics and 0.01% in rinse-off cosmetics, subject to the regulation's detailed entries and transition rules. These are labeling triggers, not general safety caps. Separate concentration restrictions may apply. Some entries group substances or define a required common declaration name, so literal single-name matching is inadequate.
5. 2026 and 2028 transition dates matter
The EU amendment allowed products not complying with the new provisions to be placed on the market until 31 July 2026, and certain products already placed on the market may remain available until 31 July 2028 under transitional conditions. In October 2026 the placing-on-market deadline has passed. Do not confuse first placement with continued availability of qualifying earlier stock. Verify the consolidated legal text and later amendments at the decision date.
6. A simple allergen-contribution example
Suppose a leave-on finished product receives limonene contributions of 0.0008% from A and 0.0007% from B. Their combined 0.0015% exceeds the EU 0.001% individual-labeling trigger. Checking each source in isolation would miss the declaration requirement. This fictional example determines a labeling question only; it does not establish overall safety or compliance with separate quantitative restrictions.
7. What to do when consumers report adverse reactions
If a customer reports a rash after using a fragrance, take the report seriously, advise discontinuation pending assessment and recommend medical attention for severe symptoms. Document the batch, timeline and use context with appropriate privacy safeguards and report through the responsible safety process as applicable. Do not blame the user or dismiss the possibility of an adverse reaction because a certificate is on file.
Case: allergen contributions must be summed
Two ingredients separately contribute 0.0008% and 0.0007% limonene to a hypothetical EU leave-on cosmetic. Neither contribution alone reaches the 0.001% trigger, but their sum of 0.0015% does. The outcome is correct declaration review and a separate safety check, never omission of a supplier contribution.
Practical exercise
Construct a hypothetical EU leave-on allergen tally. Start with X at 0.0009%, Y at 0.0012% and Z at 0.0006%, then add a second supplier contribution for each. Sum by substance, compare with the appropriate legal declaration threshold and explain why labeling and safety are separate tasks.
Three illustrated concepts
Sensitization assessment
- Hazard: sensitizing potential
- Exposure: dose and use context
- Irritation differs from immune allergy
- Natural does not mean allergy-free
EU individual allergen declaration
- Leave-on: above 0.001%
- Rinse-off: above 0.01%
- Disclosure trigger ≠ safety limit
- Follow substance-specific rules
Sum contributions from every source
- Source A: 0.0008%
- Source B: 0.0007%
- Total: 0.0015%
- Decision: individual ingredient declaration?
Technical glossary
- Allergic contact dermatitis
- Immune-mediated contact skin inflammation in a sensitized individual.
- Labeling threshold
- Legal trigger for required individual ingredient disclosure.
- Contribution from other sources
- Additional amount of the same regulated constituent from multiple materials.
Official references and verification
Regulatory educational content based on the linked primary sources. Not legal advice, a safety approval or a substitute for checking current requirements.
